Adynovi haemophilia a
Baxalta seeks European marketing rights for haemophilia drug
March 3, 2016Research and Development, Sales and Marketing Adynovi haemophilia a, Baxalta
Baxalta says it has filed for marketing authorisation for its haemophilia drug Adynovi with European regulators. The European Medicines Agency …
Latest content
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
